BP GHK-Cu 50mg Pre-Filled Pen
GHK-Cu 50mg is a single-peptide injectable research compound containing 50 mg total GHK-Cu (Copper Tripeptide-1) per pen.
The prefilled pen allows precise dose selection of 1 mg, 2 mg, or 3 mg per injection, delivering controlled and consistent administration under research or practitioner guidance.
For research use only.
To be handled by qualified professionals in appropriate settings.
What GHK-Cu 50mg Is Used For
GHK-Cu is a naturally occurring copper-binding peptide widely studied in regenerative and cosmetic research.
Research observations associate GHK-Cu with:
Skin regeneration, elasticity, and collagen synthesis
Hair growth support and reduced follicular inflammation
Improved nail strength and resilience
Anti-inflammatory and wound-healing activity
Support for overall tissue repair and cellular renewal
How GHK-Cu Works
GHK-Cu functions by binding copper ions and modulating multiple biological pathways involved in repair and regeneration. Research suggests it may:
Support gene expression related to tissue repair, collagen production, and skin renewal
Reduce markers associated with inflammation and oxidative stress
Promote angiogenesis (new blood vessel formation) and stem-cell activity
Support TGF- and integrin pathways involved in healing processes
Its ability to influence multiple cell types and signaling pathways makes it a key focus in regenerative research.
Important Information Before Use
Do Not Use If You
Are allergic to GHK-Cu or formulation components
Are pregnant or breastfeeding
Are not trained in peptide handling or injection protocols
How to Use GHK-Cu 50mg
Use this product only as instructed by your research protocol or supervising practitioner.
Administration Route: Subcutaneous injection via prefilled pen.
Dosage Information
Total per pen: 50 mg GHK-Cu
Selectable doses: 1 mg / 2 mg / 3 mg
Research protocols commonly involve daily or alternate-day administration, depending on study objectives
Possible Side Effects
Like all research peptides, GHK-Cu may cause side effects, although not everyone will experience them.
Common
Mild injection-site irritation
Temporary fatigue or light-headedness